IOL-Sparing Technique in UGH Syndrome

Show Description +

Uveitis-glaucoma-hyphema (UGH) syndrome can result from sulcus placement of an IOL and is typically managed with IOL repositioning or exchange. In this video, Fatma F. Shakarchi, MD, MSc; Pedro Tetelbom, MD; and Sami Uwaydat, MD, FASRS, present a case of an 81-year-old man with pseudophakia in both eyes, monovision in the right eye, and a history of pars plana vitrectomy for vitreous hemorrhage in the same eye. He presented with recurrent hyphema and elevated IOP for over a year, with visual acuity of hand motion and IOP of 34 mm Hg OD. Evaluation revealed UGH syndrome due to one haptic of a one-piece acrylic IOL positioned in the sulcus. Surgeons performed haptic amputation without IOL exchange or repositioning. Postoperatively, the patient’s VA improved to 20/20 (near), the IOL remained well-centered, and there was no recurrence of hyphema or vitreous hemorrhage for over 1 year.

Posted: 7/07/2025

Keywords:

UGH Syndrome

IOL-Sparing Technique in UGH Syndrome

Uveitis-glaucoma-hyphema (UGH) syndrome can result from sulcus placement of an IOL and is typically managed with IOL repositioning or exchange. In this video, Fatma F. Shakarchi, MD, MSc; Pedro Tetelbom, MD; and Sami Uwaydat, MD, FASRS, present a case of an 81-year-old man with pseudophakia in both eyes, monovision in the right eye, and a history of pars plana vitrectomy for vitreous hemorrhage in the same eye. He presented with recurrent hyphema and elevated IOP for over a year, with visual acuity of hand motion and IOP of 34 mm Hg OD. Evaluation revealed UGH syndrome due to one haptic of a one-piece acrylic IOL positioned in the sulcus. Surgeons performed haptic amputation without IOL exchange or repositioning. Postoperatively, the patient’s VA improved to 20/20 (near), the IOL remained well-centered, and there was no recurrence of hyphema or vitreous hemorrhage for over 1 year.

Posted: 7/07/2025

Keywords:

UGH Syndrome

Please log in to leave a comment.

More in Cataract

Innovations in Drug Delivery: A Drug Delivering IOL

I. Paul Singh, MD; and Douglas McGraw, DO

Phacoemulsification With Real-Time Remote Collaboration

Ernesto Calvo, MD; Salomon Abouganem, MD; and Eric Rosenberg, DO

Case-Based Confidence With LenSx® OnAxis

Zarmeena Vendal, MD; Scott LaBorwit, MD; and Heather Weissman, MD

OnAxis Workflow Confidence From Clinic to OR

Zarmeena Vendal, MD; Scott LaBorwit, MD; and Heather Weissman, MD